Li K - Search Results

1

Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins.

Li K, Huo Q, Dimmitt NH, Qu G, Bao J, Pandya PH, Saadatzadeh MR, Bijangi-Vishehsaraei K, Kacena MA, Pollok KE, Lin CC, Li BY, Yokota H. Li K, et al. Among authors: li by. Elife. 2023 Mar 21;12:e83768. doi: 10.7554/eLife.83768. Elife. 2023. PMID: 36943734 Free PMC article.

2

Prostate cancer-associated urinary proteomes differ before and after prostatectomy.

Feng Y, Liu S, Zha R, Sun X, Li K, Wu D, Aryal UK, Koch M, Li BY, Yokota H. Feng Y, et al. Among authors: li by, li k. Ther Adv Med Oncol. 2022 Oct 27;14:17588359221131532. doi: 10.1177/17588359221131532. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36324734 Free PMC article.

3

Intracellular and extracellular moesins differentially regulate Src activity and β-catenin translocation to the nucleus in breast cancer cells.

Ahandoust S, Li K, Sun X, Li BY, Yokota H, Na S. Ahandoust S, et al. Among authors: li by, li k. Biochem Biophys Res Commun. 2023 Jan 8;639:62-69. doi: 10.1016/j.bbrc.2022.11.075. Epub 2022 Nov 29. Biochem Biophys Res Commun. 2023. PMID: 36470073

4

Erratum: Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum.

Sun X, Li K, Hase M, Zha R, Feng Y, Li BY, Yokota H. Sun X, et al. Among authors: li by, li k. Theranostics. 2023 Jan 1;13(1):16-19. doi: 10.7150/thno.79085. eCollection 2023. Theranostics. 2023. PMID: 36593961 Free PMC article.

5

The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs).

Li K, Huo Q, Li BY, Yokota H. Li K, et al. Among authors: li by. Proteomes. 2023 Jan 18;11(1):5. doi: 10.3390/proteomes11010005. Proteomes. 2023. PMID: 36810561 Free PMC article. Review.

6

Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis.

Li K, Sun X, Minami K, Tamari K, Ogawa K, Li H, Ma H, Zhou M, Na S, Li BY, Yokota H. Li K, et al. Among authors: li h, li by. Theranostics. 2023 Feb 5;13(4):1247-1263. doi: 10.7150/thno.80294. eCollection 2023. Theranostics. 2023. PMID: 36923539 Free PMC article.

7

Three unconventional maxims in the natural selection of cancer cells: Generation of induced tumor-suppressing cells (iTSCs).

Li K, Huo Q, Li BY, Yokota H. Li K, et al. Among authors: li by. Int J Biol Sci. 2023 Feb 27;19(5):1403-1412. doi: 10.7150/ijbs.79155. eCollection 2023. Int J Biol Sci. 2023. PMID: 37056934 Free PMC article. Review.

8

Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes.

Li K, Sun X, Li H, Ma H, Zhou M, Minami K, Tamari K, Ogawa K, Pandya PH, Saadatzadeh MR, Kacena MA, Pollok KE, Li BY, Yokota H. Li K, et al. Among authors: li h, li by. Genes Dis. 2022 Aug 28;10(4):1641-1656. doi: 10.1016/j.gendis.2022.08.007. eCollection 2023 Jul. Genes Dis. 2022. PMID: 37397541 Free PMC article.

9

Anticancer peptides from induced tumor-suppressing cells for inhibiting osteosarcoma cells.

Cui CP, Huo QJ, Xiong X, Li KX, Ma P, Qiang GF, Pandya PH, Saadatzadeh MR, Bijangi Vishehsaraei K, Kacena MA, Aryal UK, Pollok KE, Li BY, Yokota H. Cui CP, et al. Among authors: li kx, li by. Am J Cancer Res. 2023 Sep 15;13(9):4057-4072. eCollection 2023. Am J Cancer Res. 2023. PMID: 37818062 Free PMC article.

10

Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma.

Li K, Huo Q, Minami K, Tamari K, Ogawa K, Na S, Fishel ML, Li BY, Yokota H. Li K, et al. Among authors: li by. Cancers (Basel). 2023 Oct 10;15(20):4917. doi: 10.3390/cancers15204917. Cancers (Basel). 2023. PMID: 37894284 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25,400 results

Search Page